CD274 and cancer: ETV4 bound to the PD-L1–L2-SE region, which is dependent on the activation of the BRAF/TAK1/ERK axis through integrin αvβ3 stimulation, enhances the expression of PD-L2 to mediate immune escape in cancer cells [66].